BIOCRYST PHARMACEUTICALS INC — United States · Federal contract register · Supplier record: 22 contracts, all years ($340,856,054 · Jan 2007 – May 2026); $16.0M since January 2024 (12 contracts · 2 agencies); — rank in the line (of 102 suppliers · 0.0%); 2 agencies never served ($76.8M on the line without BIOCRYST PHARMACEUTICALS INC).
Assay record ASY-US-0C7GJ9P0TH · Cite as: Assay Systems, “BIOCRYST PHARMACEUTICALS INC in the USAspending register”, https://assay-systems.com/register/us/biocryst-pharmaceuticals-inc/
22
contracts, all years
$340,856,054 · Jan 2007 – May 2026
$16.0M
since January 2024
12 contracts · 2 agencies
—
rank in the line
of 102 suppliers · 0.0%
2
agencies never served
$76.8M on the line without BIOCRYST PHARMACEUTICALS INC
Own record by year
2020 onward
$2.6M
$199K
$56.7K
$15.5M
$389K
$182K
2020202120222023202420252026
Who buys from BIOCRYST PHARMACEUTICALS INC
since January 2024
2agencies
$16.0Mpaid
86.5%top buyer
Department of Health and Human Services86.5%
$13,877,674
Department of Veterans Affairs13.5%
$2,162,057
The line
since January 2024
$566Mline value
124contracts
4agencies
102suppliers
70.3%held by top ten
Health r&d services; health care services; experimental development (AN13)
$239M
$109M
$218M
202420252026Jan–Sep
—of 102 suppliers
$0BIOCRYST PHARMACEUTICALS INC in the line
0.0%share of the line
Agencies that buy the line and never bought from BIOCRYST PHARMACEUTICALS INC
Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.